Browse EX-10 agreements

---

Exhibit 10.1

AMENDMENT TO THE ENTERA BIO LTD. 2018 EQUITY INCENTIVE PLAN

This Amendment (the “Amendment”) to the 2018 Equity Incentive Plan (the “2018 Plan”) of Entera Bio Ltd., a company organized under the laws of the State of Israel (the “Company”), is made effective as of July 14, 2026. Unless otherwise specifically defined herein, each capitalized term used herein shall have the meaning afforded such term under the 2018 Plan.

WHEREAS, the Board of Directors of the Company (the “Board”) via meeting of the Board held on May 7, 2026, determined it to be in the best interests of the Company to amend the 2018 Plan to increase the aggregate number of ordinary shares, par value NIS 0.0000769 per share (“Ordinary Shares”) of the Company authorized for issuance thereunder by a one-time additional amount of 2,500,000 Ordinary Shares (the “Share Increase”); and

WHEREAS, at the Company’s 2026 annual meeting of shareholders held on July 14, 2026, the Company’s shareholders approved the Share Increase.

…

NAI-5012918200v5

EXHIBIT 10.1

EXECUTION VERSION

SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

THIS SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”) is entered into as of July 15, 2026, by and among CrossAmerica Partners LP, a Delaware limited partnership (the “Partnership”), Lehigh Gas Wholesale Services, Inc., a Delaware corporation (“Services” and, together with the Partnership, the “Borrowers”), the Guarantors (as defined below) party hereto, each of the Lenders and L/C Issuers party hereto and Citizens Bank, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”) and as Collateral Agent (in such capacity, the “Collateral Agent”).

W I T N E S S E T H:

…

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT

THIS SECOND AMENDMENT to Loan and Security Agreement (this “Amendment”) is entered into as of July 15, 2026, by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 115 South Union Street, Suite 300, Alexandria, VA 22314 (“Oxford”), as collateral agent (in such capacity, “Collateral Agent”), the Lenders listed on Schedule 1.1 of the Loan Agreement (as defined herein) or otherwise a party to the Loan Agreement from time to time, including Oxford in its capacity as a Lender, OXFORD FINANCE CREDIT FUND II LP, by its manager Oxford Finance Advisors, LLC, with an office located at 115 South Union Street, Suite 300, Alexandria, VA 22314 and OXFORD FINANCE CREDIT FUND III LP, by its manager Oxford Finance Advisors, LLC, with an office located at 115 South Union Street, Suite 300, Alexandria, VA 22314 (each a “Lender” and collectively, the “Lenders”), and INHIBRX BIOSCIENCES, INC., a Delaware corporation with an office located at 11025 North Torrey Pines Road, Suite 140, La Jolla, CA 92037 (“Borrower”).

…

SETTLEMENT AND PATENT LICENSE AGREEMENT

VPR Brands, LP | R.J. Reynolds Vapor Company

U.S. Patent No. 8,205,622 B2

* *

This SETTLEMENT AND PATENT LICENSE AGREEMENT (the “Agreement”) is made and entered into and is effective as of July 10, 2026, (the “Effective Date”) by and between VPR Brands, LP, a limited partnership organized under the laws of the State of Delaware, having a place of business at 1141 Sawgrass Corporate Parkway, Sunrise, Florida 33323 (“Licensor” or “VPR”), and R.J. Reynolds Vapor Company, a corporation organized under the laws of the State of North Carolina, having a place of business at 401 North Main Street, Winston-Salem, North Carolina 27101 (“Licensee” or “RJR”). Licensor and Licensee are each individually referred to as a “Party,” and collectively as the “Parties.”

RECITALS

** **

WHEREAS, Licensor is the owner of all right, title, and interest in and to, including the right to sue for past, present, and future infringement of, U.S. Patent No. 8,205,622 B2;

…

Certain information in this document has been omitted and replaced with “[***]”. Such identified information has been omitted from this document because it is not material and is of the type that the registrant treats as private or confidential.

EFFECTIVE JULY 10, 2026

David R. Vetter

16202 Bay Vista Drive

Clearwater, Florida 33760

Re: Updated terms and conditions of employment

Dear David:

TD SYNNEX Corporation (the “Company”) is pleased to offer you updated terms and conditions of employment pursuant to this employment agreement (the “Agreement”) related to your position of Chief Legal Officer of the Company on the following terms effective as of July 10, 2026 (the “Effective Date”):

1.Terms of Employment.

…

Execution Version

REVOLVING CREDIT, GUARANTY

AND

SECURITY AGREEMENT

AMONG

RESOURCES CONNECTION, INC.

RESOURCES CONNECTION LLC

AND

EACH PERSON JOINED HERETO FROM TIME TO TIME AS A BORROWER

AS BORROWERS,

VERACITY CONSULTING GROUP, LLC

REFERENCE POINT LLC

AND

EACH PERSON JOINED HERETO FROM TIME TO TIME AS A GUARANTOR

AS GUARANTORS,

EACH FINANCIAL INSTITUTION PARTY HERETO FROM TIME TO TIME AS A LENDER

AND

PNC BANK, NATIONAL ASSOCIATION

AS AGENT

JULY 15, 2026

    1

---

LIST OF EXHIBITS AND SCHEDULES

Exhibits

Exhibit 1.2        Borrowing Base Certificate

Exhibit 1.2(a)        Compliance Certificate

Exhibit 2.1(a)         Revolving Credit Note

Exhibit 2.4(a)        Swing Loan Note

Exhibit 5.5(b)        Financial Projections

Exhibit 8.1(g)        Financial Condition Certificate

Exhibit 17.3         Commitment Transfer Supplement

Exhibit 3.10(e)(iii)        Form of U.S. Tax Compliance Certificate

Exhibit 3.10(e)(iv)(1)        Form of U.S. Tax Compliance Certificate

Exhibit 3.10(e)(iv)(2)        Form of U.S. Tax Compliance Certificate

…

HEALTHLYNKED CORPORATION

** **

Interim Chief Financial Officer Consulting Engagement Letter

** **

Date: July 10, 2026

** **

Mr. George O’Leary

Dear George,

HealthLynked Corporation (“HealthLynked” or the “Company”) is pleased to offer you the opportunity to serve as the Company’s Interim Chief Financial Officer during one of the most important periods in the Company’s history.

The purpose of this engagement is to provide executive financial leadership necessary to successfully complete the Company’s uplisting to the Nasdaq Capital Market, strengthen the Company’s financial infrastructure, and assist management in positioning HealthLynked for its next phase of growth and capital formation.

** **

Position

You will serve as Interim Chief Financial Officer of HealthLynked Corporation, reporting directly to the Chief Executive Officer and working closely with the Board of Directors.

…

CONFIDENTIAL

Karthik Gopalakrishnan

Vega Links Inc.

Chief Executive Officer

313 Bryant Court

Palo Alto, CA 94301

Re: Binding Letter of Intent for Acquisition of VEGA LINKS, Inc.

Dear Karthik,

This binding letter of intent (this “Letter”), together with the term sheet attached hereto, sets forth our mutual understanding regarding the terms of an acquisition of Vega Links Inc. and its affiliate(s) (collectively “VLI”) by Palomino Laboratories Inc. (“PLI”) in a transaction structured as an acquisition of all of the issued and outstanding shares of capital stock of VLI by PLI (the “Acquisition”). It is understood that any such transaction includes our mutual agreement on terms, and the entering into by VLI and PLI (each, a “Party” and collectively, the “Parties”) of definitive documents for the Acquisition and neither Party shall have any obligations other than as explicitly set forth herein unless and until a definitive agreement is entered into by and between VLI and PLI.

…

NON-BINDING LETfER OF INTENT

Date: July 3, 2026

To: Bio-Path Holdings, Inc.

Attn: Vik Grover

From: Farrington Capital Group LLC. and/or its designated affiliate, VantioBio and or Vantio Alpha Fund

Bio-Path Holdings, Inc. ("Bio-Path") and Farrington Capital Group LLC. and/or its designated affiliate, VantioBio and or Vantio Alpha Fund (collectively,"Buyer") are pleased to outline the principal terms of a proposed strategic transaction. This Letter of Intent is intended to provide a framework for diligence and negotiation concerning an exclusive out-license, asset acquisition, or similar transaction involving the DNAbilize platform and related Bio-Path programs, studies, data, know-how, intellectual property, regulatory materials, manufacturing information, and development documentation.

Transaction Scope

The contemplated transaction would include some or all of the following, to the extent owned, controlled, or licensable by Bio-Path:

•          Prexigebersen (BP1001), including related AML studies and supporting materials.

…

LETTER OF INTENT – PARTNERSHIP AND INVESTMENT BIO-PATH HOLDINGS, INC. – ALTFINS, J. S. A.

** **

Executive Summary

** **

Bio-Path Holdings, Inc. (OTC: BPTH) and altFINS are exploring a strategic partnership whereby BPTH establishes a Gen2 digital asset treasury - moving beyond passive Bitcoin accumulation toward a multi-asset, systematically managed cryptocurrency portfolio informed by altFINS’ institutional-grade on-chain fundamentals and technical analysis.

This proposal outlines the partnership structure, a phased treasury deployment plan, the specific altFINS capabilities BPTH would leverage, and how BPTH can differentiate itself from first-generation treasury adopters.

Metric	Value
Public companies holding crypto (mid-2026)	~200+
Collective holdings at peak	$180BN

Market Context: Gen1 vs. Gen2 Treasury Strategies

…

---

Exhibit 10.1

EXECUTION VERSION

AMENDMENT NO. 7 TO MASTER FRAMEWORK AGREEMENT

This AMENDMENT NO. 7 TO MASTER FRAMEWORK AGREEMENT (this “Amendment”), is made and entered into as of July 10, 2026 (the “Amendment Date”), by and among each of:

(A)

MUFG Bank, Ltd., a Japanese banking corporation (“MUFG”), as buyer (“Buyer”);

(B)

TXU Energy Retail Company LLC, a Texas limited liability company (“TXU”), as seller (the “Seller”);

(C)

each originator party hereto (each, an “Originator”; and together with the Seller, each a “Seller Party” and collectively, the “Seller Parties”);

(D)

TXU, as agent for the Seller Parties (in such capacity, the “Seller Party Agent”); and

(E)

solely with respect to Section 4.4 hereof, Vistra Operations Company LLC, as guarantor (the “Guarantor”),

…

***Execution Version ***

TERM LOAN CREDIT AGREEMENT

dated as of

July 15, 2026

Among

BAKER HUGHES HOLDINGS LLC,

as the Borrower,

BAKER HUGHES COMPANY,

as the Parent Guarantor,

The Lenders Party Hereto,

and

BANK OF AMERICA, N.A., as Administrative Agent

$1,000,000,000 TERM LOAN CREDIT FACILITY

BOFA SECURITIES, INC.,

as sole Bookrunner and sole Lead Arranger

---

**TABLE OF CONTENTS **

| | | | | | | | | ------------------------------------------ | - | ------------------------------------------------- | : | :--: | -: | - | | | | | | | | | | | | | | Page | | | | ARTICLE I DEFINITIONS | | | | | 1 | |

…